Hood River Capital Management LLC / AXSM
Hood River Capital Management LLC’s Axsome Therapeutics Inc. Position
Does Hood River Capital Management LLC own Axsome Therapeutics Inc. (AXSM)? Yes — 371.5K shares worth $63M (+0.63% of its 13F portfolio) as of Q1 2026, up from 366.2K shares the prior filed quarter.
Position Value
$63M
Q1 2026
Shares
371.5K
% of Portfolio
+0.63%
Quarters Held
13
currently held
Position History AXSM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 371.5K | $63M | +0.63% |
| Q4 2025 | 366.2K | $67M | +0.73% |
| Q3 2025 | 360.0K | $44M | +0.52% |
| Q2 2025 | 371.1K | $39M | +0.54% |
| Q4 2024 | 644.8K | $55M | +0.81% |
| Q3 2024 | 625.1K | $56M | +0.91% |
| Q2 2024 | 549.1K | $44M | +0.92% |
| Q1 2024 | 520.8K | $42M | +0.93% |
| Q4 2023 | 392.8K | $31M | +0.86% |
| Q3 2023 | 383.3K | $27M | +0.86% |
| Q2 2023 | 384.4K | $28M | +0.82% |
| Q1 2023 | 380.8K | $23M | +0.76% |
| Q4 2022 | 460.3K | $36M | +1.29% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hood River Capital Management LLC’s full portfolio or all institutional holders of AXSM.